Critical care researcher, Medical University of South Carolina (MUSC)
Appears in 1 story
Leading the INSPIRE trial feasibility study on pulse oximetry accuracy across skin tones
Masimo's smartSET pulse oximetry platform now detects atrial fibrillation, its second AI-powered clinical event feature after opioid-induced respiratory depression. The company announced the FDA clearance on October 17, 2026.
Updated 3 hours ago
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
